These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26976353)

  • 1. 5HT3 receptors: Target for new antidepressant drugs.
    Gupta D; Prabhakar V; Radhakrishnan M
    Neurosci Biobehav Rev; 2016 May; 64():311-25. PubMed ID: 26976353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel 5HT3 antagonist 4i (N-(3-chloro-2-methylphenyl)quinoxalin-2-carboxamide) prevents diabetes-induced depressive phenotypes in mice: Modulation of serotonergic system.
    Gupta D; Thangaraj D; Radhakrishnan M
    Behav Brain Res; 2016 Jan; 297():41-50. PubMed ID: 26454237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression.
    Gupta D; Radhakrishnan M; Kurhe Y; Thangaraj D; Prabhakar V; Kanade P
    Acta Pharmacol Sin; 2014 Dec; 35(12):1493-503. PubMed ID: 25418380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5HT3 receptor antagonist (ondansetron) reverses depressive behavior evoked by chronic unpredictable stress in mice: modulation of hypothalamic-pituitary-adrenocortical and brain serotonergic system.
    Gupta D; Radhakrishnan M; Kurhe Y
    Pharmacol Biochem Behav; 2014 Sep; 124():129-36. PubMed ID: 24909071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a novel 5-HT3 receptor antagonist 4i, in corticosterone-induced depression-like behavior and oxidative stress in mice.
    Gupta D; Radhakrishnan M; Kurhe Y
    Steroids; 2015 Apr; 96():95-102. PubMed ID: 25668613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: possible implication of serotonergic system.
    Gupta D; Radhakrishnan M; Kurhe Y
    Eur J Pharmacol; 2014 Dec; 744():59-66. PubMed ID: 25284215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms linking depression co-morbid with obesity: An approach for serotonergic type 3 receptor antagonist as novel therapeutic intervention.
    Kurhe Y; Mahesh R
    Asian J Psychiatr; 2015 Oct; 17():3-9. PubMed ID: 26243683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character.
    Dukat M; Alix K; Worsham J; Khatri S; Schulte MK
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5945-8. PubMed ID: 24035337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice.
    Kurhe Y; Radhakrishnan M; Gupta D; Devadoss T
    J Pharm Pharmacol; 2014 Jan; 66(1):122-32. PubMed ID: 24180368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QCM-4, a 5-HT₃ receptor antagonist ameliorates plasma HPA axis hyperactivity, leptin resistance and brain oxidative stress in depression and anxiety-like behavior in obese mice.
    Kurhe Y; Mahesh R; Devadoss T
    Biochem Biophys Res Commun; 2015 Jan; 456(1):74-9. PubMed ID: 25446100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): blocking 5HT3 receptors enhances release of serotonin, norepinephrine, and acetylcholine.
    Stahl SM
    CNS Spectr; 2015 Oct; 20(5):455-9. PubMed ID: 26122791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropharmacological and neurochemical evaluation of N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n): a novel serotonergic 5-HT3 receptor antagonist for co-morbid antidepressant- and anxiolytic-like potential using traumatic brain injury model in rats.
    Bhatt S; Mahesh R; Jindal A; Devadoss T
    J Basic Clin Physiol Pharmacol; 2017 Mar; 28(2):93-100. PubMed ID: 27662644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models.
    Gupta D; Radhakrishnan M; Thangaraj D; Kurhe Y
    Eur J Pharmacol; 2014 Jul; 735():59-67. PubMed ID: 24747753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of dopamine transmission by 5HT2C and 5HT3 receptors: a role in the antidepressant response.
    Dremencov E; Weizmann Y; Kinor N; Gispan-Herman I; Yadid G
    Curr Drug Targets; 2006 Feb; 7(2):165-75. PubMed ID: 16475958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and pharmacological evaluation of novel 2-(4-substituted piperazin-1-yl)1, 8 naphthyridine 3-carboxylic acids as 5-HT3 receptor antagonists for the management of depression.
    Dhar AK; Mahesh R; Jindal A; Devadoss T; Bhatt S
    Chem Biol Drug Des; 2014 Dec; 84(6):721-31. PubMed ID: 24903617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium influx through presynaptic 5-HT3 receptors facilitates GABA release in the hippocampus: in vitro slice and synaptosome studies.
    Turner TJ; Mokler DJ; Luebke JI
    Neuroscience; 2004; 129(3):703-18. PubMed ID: 15541891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of antidepressant activity of novel 2-methoxy 1, 8 naphthyridine 3-carboxamides as 5-HT3 receptor antagonists.
    Mahesh R; Dhar AK; Jindal A; Bhatt S
    Chem Biol Drug Des; 2014 May; 83(5):583-91. PubMed ID: 24330585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic properties of serotonergic agents and antidepressant drugs.
    Fuller RW
    J Clin Psychiatry; 1987 Mar; 48 Suppl():5-11. PubMed ID: 3493240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piperazine analogs of naphthyridine-3-carboxamides and indole-2-carboxamides: novel 5-HT3 receptor antagonists with antidepressant-like activity.
    Dhar AK; Mahesh R; Jindal A; Bhatt S
    Arch Pharm (Weinheim); 2015 Jan; 348(1):34-45. PubMed ID: 25581677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.